NEW YORK, Sept. 28 (GenomeWeb News) - Nanogen expects to raise nearly $20 million through a stock offering to institutional investors scheduled to close today, the company said.
The San Diego-based company will sell 6.8 million shares of its common stock to investors at a price of nearly $3 per share, with 1 million warrants exercisable at $4 per share for five years.
Registering provides access to this and other free content.
Already have an account?Login Now.
Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.
Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.
China is embracing preimplantation genetic diagnosis, Nature News reports.
In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.